Prioritize clarity over legal complexity. Write as an informational guide, not a legal warning.
Quick Answer
Adrafinil is not clearly listed as a controlled drug in the UK, but its legal position is more restricted than “legal and freely available” because it may fall under UK rules on psychoactive substances when sold, supplied, imported, or marketed for human consumption. It is not a routine UK-licensed prescription medicine, and there is no standard UK pharmacy pathway comparable to licensed medicines such as modafinil. Personal possession is generally treated differently from supply or import, but online ordering and cross-border shipment may be subject to review, refusal, or seizure depending on how the product is presented and intended to be used.
Drug Overview
Generic name: Adrafinil
Other names: CRL-40028; adrafinil powder or adrafinil capsules in supplement-style listings
Brand names: Olmifon was a historical brand used in France; it is not a routine UK medicine brand
Drug class: Wakefulness-promoting compound; modafinil precursor/prodrug in pharmacological discussions
Common uses: Historically studied or used in some contexts for wakefulness-related symptoms, but it is not a standard licensed UK treatment pathway
Adrafinil is commonly discussed online because it is chemically related to modafinil. In the body, adrafinil is often described as a precursor to modafinil, meaning it may be metabolised into modafinil-like active compounds. That association is the main reason people search whether adrafinil is legal in the UK or whether adrafinil is controlled.
However, UK law does not treat every wakefulness-promoting substance in the same way. Modafinil is a licensed prescription-only medicine in the UK. Adrafinil is different. It is not commonly available as a UK-licensed medicine, is not normally prescribed through standard UK medical channels, and may raise questions under rules covering psychoactive substances if it is sold or imported for human use.
The most important point is that “not controlled” does not automatically mean “legal to buy online.” UK medicines law, psychoactive-substance law, customs controls, and product-safety rules can all matter at the same time.
Legal and Controlled Status in the UK
Is Adrafinil Legal and Controlled in the UK?
Adrafinil does not appear to be named as a controlled drug in the ordinary UK controlled-drug framework. UK controlled drugs are classified under the Misuse of Drugs Act 1971 and related regulations, and the Home Office publishes a practical controlled drugs list under UK misuse of drugs legislation showing commonly encountered substances and their classifications.
That said, adrafinil’s legal status cannot be reduced to “not controlled, therefore unrestricted.” In the UK, substances that are not scheduled under the Misuse of Drugs Act may still be restricted if they are capable of producing a psychoactive effect and are supplied, offered, imported, or exported for human consumption. This is where the Psychoactive Substances Act 2016 becomes relevant.
In practical terms, adrafinil is best described as not clearly scheduled as a controlled drug, but not freely marketable for human consumption. The most sensitive areas are online sales, importation, commercial supply, and product claims.
Is it a controlled substance?
Adrafinil is not generally treated as a named controlled drug in the same way as substances listed under Class A, Class B, or Class C of the Misuse of Drugs Act 1971. It is also not commonly treated as a controlled medicine like many opioids, benzodiazepines, or stimulant drugs.
However, the UK uses more than one legal framework. The Psychoactive Substances Act 2016 applies across the UK and targets substances capable of producing a psychoactive effect unless an exemption applies. The government’s overview of the Psychoactive Substances Act 2016 explains that the Act covers production, supply, offers to supply, possession with intent to supply, possession in custodial premises, import, and export of psychoactive substances.
Because adrafinil is promoted online for wakefulness and cognitive effects, it may be treated as relevant to psychoactive-substance rules when supplied or imported for human consumption. That does not make it a “controlled drug” in the narrow Misuse of Drugs Act sense, but it can still make sale or import problematic.
Is it legal?
The answer depends on what activity is being discussed.
For simple possession, adrafinil is not usually discussed as a named controlled drug. Personal possession outside custodial settings is generally treated differently from supply or import. However, possessing a product does not automatically confirm that the way it was obtained, imported, marketed, or supplied complied with UK law.
For sale, supply, import, or online distribution, the position is more restrictive. A seller offering adrafinil for human consumption in the UK may face issues under psychoactive-substance rules, medicines rules, or product-safety enforcement. A buyer ordering adrafinil from abroad may also find that the shipment is delayed, refused, or seized.
For medical use, adrafinil does not have the same routine status as a licensed UK medicine. It is not an ordinary over-the-counter product, and it is not commonly supplied by UK pharmacies as a standard licensed prescription item.
Is a prescription required?
There is no ordinary UK prescription pathway for adrafinil comparable to a licensed medicine listed in UK product information. It should not be described simply as a normal prescription-only medicine in the same way as modafinil, because adrafinil is not a standard UK-authorised product.
If adrafinil were handled as a medicinal product for human treatment, supply would need to fit within UK medicines rules. The MHRA’s guidance on supplying unlicensed medicinal products, also known as specials explains that unlicensed medicines may be manufactured, imported, distributed, or supplied only within specific professional frameworks, typically for individual patient need.
That is very different from buying a supplement online. A website selling adrafinil without medical oversight, without a prescription, or with claims about mental performance or wakefulness may not be operating within a compliant UK medicines or psychoactive-substance framework.
Possession and Use
For an individual in the UK, simple possession of adrafinil is generally not the same as possession of a named controlled drug. Adrafinil is not commonly listed as a Class A, B, or C controlled drug, so the controlled-drug possession rules that apply to scheduled substances are not the main issue.
However, there are important limits to that statement. The UK legal position changes when possession is connected with supply, resale, importation, or distribution. Holding a small quantity for personal use is not the same as holding stock for resale or importing repeated shipments. Context matters.
A person may also face practical questions if the product is not clearly labelled, appears to be a medicine, is in bulk powder form, or is associated with online supply. UK authorities may look at the quantity, packaging, intended use, claims made by the seller, and whether the product appears to be intended for human consumption.
Patients should also understand that adrafinil is not a routine NHS medicine. A UK resident seeking treatment for sleepiness, fatigue, ADHD-like symptoms, or concentration problems would normally speak with a healthcare professional rather than rely on an unlicensed online product. This is not because every non-prescribed product is automatically a controlled drug, but because the UK medicines system requires proper assessment, product quality controls, and appropriate prescribing where a medicine is needed.
Buying Adrafinil Online
Buying adrafinil online in the UK is legally and practically uncertain. Many websites sell adrafinil as a “research chemical,” “nootropic,” or “not for human consumption” product. These labels do not automatically make the transaction compliant if the surrounding marketing, customer use, or product presentation suggests human psychoactive use.
For a UK buyer, the main risk is not only whether adrafinil is controlled. The larger issue is whether the seller is lawfully supplying a psychoactive substance or an unlicensed medicinal product. If a product is marketed for wakefulness, focus, alertness, or cognitive enhancement, authorities may view it differently from a purely non-human laboratory chemical.
Online purchases also raise product-quality concerns. A buyer may not know whether the product actually contains adrafinil, whether the dose is accurate, whether contaminants are present, or whether the product was manufactured to pharmaceutical standards. This is especially relevant for powders, capsules from unknown suppliers, and products shipped from overseas sellers.
Shipments may not be delivered. A parcel may be stopped because it appears to contain a psychoactive substance, an unlicensed medicine, or a product with unclear labelling. Even where a buyer believes the product is for personal use, border review can still occur.
A lawful online pharmacy model is also unlikely to apply in the ordinary way because adrafinil is not a standard UK-licensed pharmacy medicine. A legitimate UK pharmacy would generally dispense licensed medicines or properly sourced unlicensed medicines under professional rules, not casual nootropic products sold without clinical oversight.
Import Rules
Importing adrafinil into the UK is one of the most uncertain areas. The rules depend on how the substance is classified in practice, how it is presented, whether it is intended for human consumption, and whether it is being imported personally or commercially.
If adrafinil is treated as a psychoactive substance intended for human consumption, importation may be restricted under the Psychoactive Substances Act. The Act is especially relevant because it covers import and export as well as supply. A product sold online for wakefulness or cognitive effects may therefore raise questions even if it is not named in the Misuse of Drugs Act schedules.
If adrafinil is treated as a medicinal product, importation may also raise medicines-law issues. Medicines brought into the UK for commercial supply normally require appropriate licensing and compliance. Unlicensed medicines may be supplied only through specific professional channels, not simply through consumer websites.
For personal use, there may be practical differences between carrying a small quantity while travelling and ordering repeated shipments from overseas. Even then, personal importation does not guarantee delivery. Customs, Border Force, or relevant regulators may review the package if the contents are unclear, the quantity seems inconsistent with personal use, or the product appears to be marketed unlawfully.
The safest general statement is that personal importation of adrafinil into the UK is restricted and uncertain. It should not be assumed to be allowed simply because adrafinil is not a named controlled drug.
Penalties and Risks
The practical risks around adrafinil in the UK are usually connected with shipment refusal, customs seizure, regulatory review, and non-compliant supply rather than ordinary patient pharmacy use.
A buyer may place an order and never receive the product. The parcel may be stopped because the product appears to fall within psychoactive-substance rules, medicines rules, or border controls. A seller may also refuse shipment to the UK because of the legal uncertainty.
There is also a quality risk. Adrafinil sold online may not be manufactured, packaged, or tested to the standards expected of licensed medicines. Labels may be incomplete, strengths may be inaccurate, and the substance may differ from what is advertised.
For businesses, the risks are broader. Supplying, offering to supply, advertising, or importing adrafinil for human consumption may create regulatory problems. Product claims can also matter. A page that presents adrafinil as a wakefulness or focus aid may be treated differently from a neutral chemical listing.
For individuals, the most practical issue is uncertainty. Possession of a small amount is not the same as importation or supply, but obtaining the product through overseas websites may still lead to refusal, delay, or seizure.
Official Classification Summary
| Category | UK position |
|---|---|
| Controlled substance | Not clearly listed as a named controlled drug under the usual Misuse of Drugs Act framework |
| Schedule / classification | No standard Class A, B, or C classification identified for adrafinil |
| Prescription required | No routine UK licensed prescription status identified; any medicinal supply would need a compliant professional route |
| Over-the-counter | No, not a standard UK OTC medicine |
| Personal importation | Restricted and uncertain, especially if intended for human consumption |
| Regulatory authority | Home Office, MHRA, Border Force, and relevant UK medicines regulators |
| Relevant law or act | Misuse of Drugs Act 1971, Psychoactive Substances Act 2016, Human Medicines Regulations 2012 |
| Last reviewed | 5 July 2026 |
What This Means in Practice
For a UK resident, adrafinil is not normally obtained through a standard pharmacy prescription. It is not a routine NHS medicine and is not generally available as a licensed UK product. A person seeking a regulated treatment pathway would usually be assessed by a healthcare professional, who may consider licensed alternatives where appropriate.
For travellers, bringing adrafinil into the UK may be more complicated than carrying a clearly prescribed licensed medicine. A labelled prescription bottle of a licensed medicine is easier to explain than loose capsules or powder bought from a nootropic website. Travellers should be aware that border review may focus on the product’s identity, quantity, packaging, and intended use.
For online buyers, the main point is that “not controlled” does not mean “safe to import.” Adrafinil may not be scheduled like many controlled drugs, but importation and supply for human psychoactive use may still be restricted. Product quality and authenticity are also major practical concerns.
For sellers, the position is especially sensitive. Offering adrafinil to UK customers for human use, wakefulness, focus, productivity, or similar effects may create compliance problems. This is why many suppliers avoid shipping adrafinil to the UK or use disclaimers that still may not resolve the underlying legal issue.
Brand Names and Local Availability
Adrafinil is not commonly available in the UK under a licensed medicine brand. The historical brand name most often associated with adrafinil is Olmifon, which was used in France. That does not mean Olmifon is available as a UK medicine.
In the UK context, adrafinil is more likely to appear online under generic or chemical-style names, including:
- Adrafinil
- Adrafinil powder
- Adrafinil capsules
- CRL-40028
- Olmifon, usually in historical or international references
These names should not be treated as proof of UK authorisation. A product name on a website is not the same as a UK marketing authorisation, pharmacy listing, or medicine licence.
Special Notes for the UK
The UK has several overlapping legal systems that can apply to substances like adrafinil. A product can be outside the controlled-drug schedules but still restricted under other laws. This is the central nuance for adrafinil.
There are also UK-wide and regional considerations. The Psychoactive Substances Act applies across the UK, but practical enforcement can vary depending on the facts of a case, the route of import, the seller, and the product presentation. Medicines regulation also has some post-Brexit differences between Great Britain and Northern Ireland, especially for authorised medicines and supply chains. For adrafinil, the larger point remains that it is not a routine authorised UK medicine.
Customs discretion is important. Border officials may not need to resolve every theoretical legal question before holding or reviewing a shipment. If a parcel appears to contain an unlicensed medicine, a psychoactive substance, or a product intended for human consumption without a compliant route, delivery may be interrupted.
Prescription practice is another key distinction. Modafinil may be prescribed in the UK for limited licensed indications. Adrafinil does not occupy the same position. It should not be presented as an informal substitute for a regulated prescription medicine.
Adrafinil vs Modafinil in UK Law
Adrafinil and modafinil are often discussed together, but they are not legally identical in the UK.
Modafinil is a recognised licensed prescription medicine in the UK. It is generally treated as prescription-only, meaning it can be supplied through legitimate pharmacy channels when prescribed. It is not normally treated as a controlled drug, but it is still restricted as a medicine.
Adrafinil is different. It is not a standard UK-licensed medicine and is often sold through nootropic or research-chemical channels. That makes its legal position less straightforward. The issue is not only whether adrafinil is controlled, but whether it is being supplied or imported as a psychoactive substance or unlicensed medicine.
This difference matters for consumers. A person with a prescription for modafinil has a clear medical and pharmacy route. A person ordering adrafinil powder from an overseas website does not have the same clarity.
Formulations and Product Presentation
Adrafinil is usually seen online as capsules, tablets, or powder. Product presentation matters because UK regulators may look at how the substance is packaged and marketed.
A powder sold in bulk with no medical labelling may raise different questions from a licensed medicine in a regulated pharmacy pack. Capsules advertised for focus, alertness, or wakefulness may suggest human consumption even if the seller uses “research only” language elsewhere on the page.
This is why disclaimers are not always decisive. A product labelled “not for human consumption” may still be examined in the context of the website’s marketing, customer base, dosage-style information, reviews, and shipping practices.
For consumers, formulation also affects safety. Powders can be mismeasured. Capsules may contain inaccurate amounts. Tablets or capsules from unknown sources may contain other substances. These are product-quality concerns, separate from the legal classification question.
Why “Not Controlled” Does Not Mean “Unrestricted”
Many people search for a simple answer: is adrafinil controlled in the UK? The narrow answer appears to be no, in the sense that it is not commonly listed as a named controlled drug under the Misuse of Drugs Act.
But UK law does not stop there. A non-controlled substance can still be restricted if it is:
- supplied for human psychoactive use;
- imported for human consumption;
- marketed with medicinal claims;
- sold as an unlicensed medicine;
- offered by an unregulated online supplier;
- presented in a way that raises public-health or customs concerns.
This is the most practical way to understand adrafinil’s UK status. It is not best described as a controlled drug, but it is also not best described as freely legal for consumer sale.
Traveller Considerations
Travellers entering the UK with adrafinil should be cautious. A licensed prescription medicine in original packaging is generally easier to explain than a non-standard nootropic product, especially if the product is a powder or has no pharmacy label.
A traveller carrying adrafinil may be asked what it is, why it is being carried, and whether it is for personal use. The answer may depend on the quantity, packaging, and documentation available. A small amount in clearly labelled packaging may be treated differently from bulk powder or multiple bottles.
Because adrafinil is not a routine UK medicine, a foreign prescription or doctor’s note may not resolve every issue. Documentation can help explain personal use, but it does not necessarily override UK import or psychoactive-substance restrictions.
Travellers should also remember that rules may differ in the country of departure. A product lawfully sold abroad is not automatically lawful to import into the UK.
FAQ
Is adrafinil legal in the UK?
Adrafinil is not clearly listed as a controlled drug in the UK, but that does not mean it is freely legal to sell, import, or market for human use. Supply and import may be restricted if it is treated as a psychoactive substance or unlicensed medicinal product.
Is adrafinil a controlled substance in the UK?
Adrafinil is not commonly identified as a named controlled drug under the Misuse of Drugs Act 1971. However, it may still be restricted under the Psychoactive Substances Act 2016 when supplied, offered, imported, or exported for human psychoactive use.
Do you need a prescription for adrafinil in the UK?
There is no normal UK prescription pathway for adrafinil as a licensed medicine. If handled as an unlicensed medicinal product, supply would need to fit within specific professional rules rather than ordinary consumer purchase.
Can you import adrafinil into the UK?
Importing adrafinil into the UK is restricted and uncertain, especially when the product is intended for human consumption. Shipments may be reviewed, refused, or seized depending on the product’s presentation, quantity, source, and intended use.
Is it legal to buy adrafinil online in the UK?
Buying adrafinil online is legally uncertain and may carry practical risks. Websites selling it for focus, wakefulness, or human use may raise issues under psychoactive-substance rules, medicines rules, or customs controls.
Final Note
This content is for informational purposes only and does not constitute medical advice.